| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Washington Cancer Institute, Occupational and Environmental Medicine, Washington Hospital Center, Washington, DC.
Correspondence: Address correspondence and reprint requests to: Paul H. Sugarbaker, MD, Washington Cancer Institute, Washington Hospital Center, 110 Irving St., N.W., Washington, DC 20010; Fax: 202-877-8602; E-mail:paul.sugarbaker{at}medstar.net
Background: Treatment of carcinomatosis may involve the use of heated intraperitoneal chemotherapy; the cytotoxic solution is administered in the operating room with the abdomen open so that manual distribution results in uniform treatment. The potential risk of this procedure to the operating room personnel has not been previously investigated.
Methods: Mitomycin C was perfused through the peritoneal cavity, which was partially covered by a plastic sheet. Large volumes of air were suctioned from 5 and 35 cm above the abdominal skin edge. Urine from the surgeon and from the perfusionist were assayed. Sterile gloves worn in the operating room for manipulating the viscera during treatment were assayed for their permeability to mitomycin C. All samples were analyzed by high-performance liquid chromatography.
Results: Analysis of samples of operating room air and urine from 10 procedures showed no detectable levels of mitomycin C. Six tests of three different types of gloves showed a 10-fold range of mitomycin C penetration. The least permeable gloves leaked a mean of 3.8 parts per million over 90 minutes.
Conclusions: No detectable safety hazard to the surgeon or other operating room personnel was demonstrated.
Key Words: Safety monitoring • Operating room • Hyperthermia • Intraperitoneal chemotherapy • Mitomycin C • Latex gloves
This article has been cited by other articles:
 |
|
 |
|
  L. Benoit, N. Cheynel, P. Ortega-Deballon, G. Di Giacomo, B. Chauffert, and P. Rat Closed Hyperthermic Intraperitoneal Chemotherapy with Open Abdomen: a Novel Technique to Reduce Exposure of the Surgical Team to Chemotherapy Drugs Ann. Surg. Oncol., February 1, 2008; 15(2): 542 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gesson-Paute, G. Ferron, F. Thomas, E. C. de Lara, E. Chatelut, and D. Querleu Pharmacokinetics of Oxaliplatin During Open Versus Laparoscopically Assisted Heated Intraoperative Intraperitoneal Chemotherapy (HIPEC): An Experimental Study Ann. Surg. Oncol., January 1, 2008; 15(1): 339 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Korinth, K. Schmid, O. Midasch, M. I. Boettcher, J. Angerer, and H. Drexler Investigations on Permeation of Mitomycin C Through Double Layers of Natural Rubber Gloves Ann. Hyg., October 5, 2007; (2007) mem039v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Section 10 Chemical contamination monitoring Journal of Oncology Pharmacy Practice, September 1, 2007; 13(3_suppl): 44 - 48. [PDF]
|
|
|
|
|
|
S. A. Ahmad, J. Kim, J. J. Sussman, D. A. Soldano, L. J. Pennington, L. E. James, and A. M. Lowy Reduced Morbidity Following Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion Ann. Surg. Oncol., April 1, 2004; 11(4): 387 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J. Verwaal, S. van Ruth, E. de Bree, G. W. van Slooten, H. van Tinteren, H. Boot, and F. A.N. Zoetmulder Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer J. Clin. Oncol., October 15, 2003; 21(20): 3737 - 3743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. A. Stuart, L. S. Welch, and P. H. Sugarbaker Operating Room Environmental Safety With Heated Intraperitoneal Chemotherapy Ann. Surg. Oncol., August 1, 2003; 10(7): 822 - 823. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
